SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $340 | +32.3% | 2,803 | +24.7% | 0.00% | 0.0% |
Q2 2023 | $257 | -11.7% | 2,247 | +6.6% | 0.00% | 0.0% |
Q1 2023 | $291 | -32.9% | 2,107 | -37.1% | 0.00% | -33.3% |
Q4 2022 | $434 | -99.9% | 3,349 | +1.2% | 0.00% | 0.0% |
Q3 2022 | $366,000 | +44.1% | 3,310 | -2.4% | 0.00% | +50.0% |
Q2 2022 | $254,000 | -10.6% | 3,391 | -6.8% | 0.00% | 0.0% |
Q1 2022 | $284,000 | -13.9% | 3,639 | -0.7% | 0.00% | 0.0% |
Q4 2021 | $330,000 | -13.6% | 3,666 | -11.3% | 0.00% | -33.3% |
Q3 2021 | $382,000 | +23.2% | 4,133 | +3.5% | 0.00% | +50.0% |
Q2 2021 | $310,000 | -39.1% | 3,992 | -41.6% | 0.00% | -50.0% |
Q1 2021 | $509,000 | -57.6% | 6,833 | -2.9% | 0.00% | -55.6% |
Q4 2020 | $1,200,000 | +8.5% | 7,034 | -10.7% | 0.01% | -10.0% |
Q3 2020 | $1,106,000 | +180.7% | 7,876 | -10.3% | 0.01% | +25.0% |
Q2 2020 | $394,000 | -54.2% | 8,785 | 0.0% | 0.01% | -11.1% |
Q1 2020 | $860,000 | -25.7% | 8,785 | -2.1% | 0.01% | -10.0% |
Q4 2019 | $1,158,000 | +68.8% | 8,971 | -1.6% | 0.01% | +66.7% |
Q3 2019 | $686,000 | -32.0% | 9,120 | +37.4% | 0.01% | -33.3% |
Q2 2019 | $1,009,000 | +23.5% | 6,639 | -3.2% | 0.01% | +28.6% |
Q1 2019 | $817,000 | +2.8% | 6,855 | -5.9% | 0.01% | -12.5% |
Q4 2018 | $795,000 | +1270.7% | 7,282 | +1939.8% | 0.01% | – |
Q3 2018 | $58,000 | +23.4% | 357 | 0.0% | 0.00% | – |
Q2 2018 | $47,000 | +80.8% | 357 | 0.0% | 0.00% | – |
Q1 2018 | $26,000 | – | 357 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |